Utah Medical Products AAQS 2025

Utah Medical Products AAQS

Ticker

UTMD

ISIN

US9174881089

WKN

882656

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Utah Medical Products has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Utah Medical Products in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

Utah Medical Products Aktienanalyse

What does Utah Medical Products do?

Utah Medical Products Inc. (UMPI) is a US-based company specializing in medical devices and products. It was founded in 1978 and has since developed an impressive range of innovative products. UMPI began with the idea of creating a better device for monitoring pregnant women and their unborn children. The first product, called "FetalGard," was a non-invasive device for quickly and accurately measuring fetal heart rates. This technology was revolutionary at the time and helped doctors and nurses make accurate diagnoses and ensure optimal obstetric care. UMPI has expanded its product range and now covers a variety of medical specialties, including gynecology/restorative, neonatology/perinatology, and blood pressure measurement. In the gynecology/restorative field, UMPI offers a wide range of products to support women's medical needs, including devices for the diagnosis and treatment of cervical cancer, obstetric instruments, and products for post-gynecological surgery recovery. The neonatology/perinatology field includes products for preterm birth prevention and support of premature infants. UMPI, for example, has developed a variety of devices for monitoring and supporting newborns, such as the "Flexxus Hydrosense," which can contribute to measuring fluid levels in newborns. In the field of blood pressure measurement, UMPI has developed a range of devices to assist doctors and medical personnel in conducting blood pressure measurements. The company is known for its highly accurate blood pressure monitors, such as the "Deltran Plus," which can be used for blood pressure measurements in adults, children, and infants. UMPI's business model focuses on the development of high-quality medical devices. The company aims to create value through these devices and help doctors and medical personnel achieve better medical outcomes. The company is proud that its products help improve patients' lives and enhance the performance of healthcare professionals. UMPI has a network of distributors and partners worldwide who contribute to making high-quality products available in the market. The company places great importance on compliance with standards and regulations and works closely with the relevant regulatory authorities. Overall, Utah Medical Products Inc. has an excellent reputation in the medical industry and is considered a reliable provider of high-quality medical devices and products. Through its innovative technology and commitment to improving medical outcomes, the company has made a significant contribution to the medical industry and will continue to play an important role in the future. Utah Medical Products ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Frequently Asked Questions about Utah Medical Products stock

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Utah Medical Products

Our stock analysis for Utah Medical Products Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Utah Medical Products Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.